Clinical trials
Completed Metabolism, Inborn Errors trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Center for Research Resources (NCRR) | 10 |
| Kastle Therapeutics, LLC | 3 |
| Regeneron Pharmaceuticals | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Duke University | 2 |
| Fred Hutchinson Cancer Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| National Human Genome Research Institute (NHGRI) | 2 |
| New York Medical College | 2 |
| University of California, San Diego | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolism, Inborn Errors | 47 |
| Genetic Diseases, Inborn | 17 |
| Metabolic Diseases | 13 |
| Rare Diseases | 13 |
| Lysosomal Storage Diseases | 7 |
| Gaucher Disease | 5 |
| Infant, Newborn, Diseases | 5 |
| Lipid Metabolism Disorders | 5 |
| Lipid Metabolism, Inborn Errors | 5 |
| Sphingolipidoses | 5 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.